<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Astellas Pharma, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Astellas Pharma, Inc.

    Astellas Pharma Inc. is a pharmaceutical company committed to the therapeutic fields of urology, immunology including transplantation and infectious diseases, oncology, euroscience and DM complications and metabolic diseases.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      OTCPink
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $17,682,152,000.00
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Masao Yoshida
    • FOUNDED
      2005
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    IMAC Holdings, Inc.

    IMAC Holdings, Inc.

    IMAC Holdings, Inc. owns or manages IMAC Regeneration Centers, which combine life ...

    IMAC Holdings, Inc. owns or manages IMAC Regene...

    Filing Type:    PU
    Bioanalytical Systems, Inc.

    Bioanalytical Systems, Inc.

    BASi provides drug discovery and development services and analytical instruments t...

    BASi provides drug discovery and development se...

    Filing Type:    PU
    Pluton Biosciences, LLC

    Pluton Biosciences, LLC

    Nature is full of untapped potential. Microbes are a proven but underused resource...

    Nature is full of untapped potential. Microbes ...

    Amount Raised:    $98,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical c...

    Minerva Neurosciences, Inc. (NASDAQ: NERV) is a...

    Filing Type:    PU
    Alimera Sciences, Inc.

    Alimera Sciences, Inc.

    Alimera Sciences (NASDAQ: ALIM), founded in June 2003, is a pharmaceutical company...

    Alimera Sciences (NASDAQ: ALIM), founded in Jun...

    Filing Type:    PU
    ChemoCentryx, Inc.

    ChemoCentryx, Inc.

    ChemoCentryx is a biopharmaceutical company focused exclusively on discovering, de...

    ChemoCentryx is a biopharmaceutical company foc...

    Filing Type:    PU
    Global Cancer Technology, Inc

    Global Cancer Technology, Inc

    Global Cancer Technology (“GCT”) is an emerging medical technology company with nu...

    Global Cancer Technology (“GCT”) is an emerging...

    Amount Raised:    $82,711.00
    Fundraising Status:    EC
    Filing Type:    CF
    Terumo Corp.

    Terumo Corp.

    Terumo Corporation is a manufacturer and supplier of pharmaceuticals and medical t...

    Terumo Corporation is a manufacturer and suppli...

    Filing Type:    PU
    Hypertension Diagnostics, Inc.

    Hypertension Diagnostics, Inc.

    Hypertension Diagnostics™ designs, develops, manufactures, and markets proprietary...

    Hypertension Diagnostics™ designs, develops, ma...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.